A suboptimal 5′ splice site downstream of HIV-1 splice site A1 is required for unspliced viral mRNA accumulation and efficient virus replication

Retrovirology

Volumn 3, Issue , 2006, Pages

  Madsen, Joshua M ^a   Stoltzfus, C Martin ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; MESSENGER RNA; POL PROTEIN; TRANSACTIVATOR PROTEIN; ANTISENSE OLIGONUCLEOTIDE; PRIMER DNA; VIF PROTEIN; VIRUS RNA; VPR PROTEIN;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ALTERNATIVE RNA SPLICING; ARTICLE; CONTROLLED STUDY; EXON; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PHENOTYPE; PLASMID; PROTEIN EXPRESSION; RNA STABILITY; VIRUS MUTANT; VIRUS REPLICATION; WESTERN BLOTTING; CELL LINE; ENHANCER REGION; GENETICS; IMMUNOLOGY; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ALTERNATIVE SPLICING; BASE SEQUENCE; CELL LINE; DNA PRIMERS; ENHANCER ELEMENTS, GENETIC; EXONS; GENE PRODUCTS, VIF; GENE PRODUCTS, VPR; HELA CELLS; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDES, ANTISENSE; PLASMIDS; RNA, MESSENGER; RNA, VIRAL; VIF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; VIRUS REPLICATION; VPR GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 33645034592     PISSN: 17424690     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-3-10     Document Type: Article

References (26)

1. Neumann M, Harrison J, Saltarelli M, Hadziyannis E, Erfle V, Felber BK, Pavlakis GN: Splicing variability in HIV type I revealed by quantitative RNA polymerase chain reaction. AIDS Res Hum Retroviruses 1994, 10(11):1531-1542.
2. Purcell DF, Martin MA: Alternative splicing of human immuno-deficiency virus type I mRNA modulates viral protein expression, replication, and infectivity. J Virol 1993, 67(11):6365-6378.
3. O'Reilly MM, McNally MT, Beemon KL: Two strong 5′ splice sites and competing, suboptimal 3′ splice sites involved in alternative splicing of human immunodeficiency virus type I RNA. Virology 1995, 213(2):373-385.
4. Si Z, Amendt BA, Stoltzfus CM: Splicing efficiency of human immunodeficiency virus type I tat RNA is determined by both a suboptimal 3′ splice site and a 10 nucleotide exon splicing silencer element located within tat exon 2. Nucleic Acids Res 1997, 25(4):861-867.
5. Staffa A, Cochrane A: The tat/rev intron of human immunodeficiency virus type I is inefficiently spliced because of suboptimal signals in the 3′ splice site. J Virol 1994, 68(5):3071-3079.
6. Amendt BA, Si ZH, Stoltzfus CM: Presence of exon splicing silencers within human immunodeficiency virus type I tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors. Mol Cell Biol 1995, 15(8):4606-4615.
7. Caputi M, Freund M, Kammler S, Asang C, Schaal H: A bidirectional SF2/ ASF- and SRp40-dependent splicing enhancer regulates human immunodeficiency virus type I rev, env, vpu, and nef gene expression. J Virol 2004, 78(12):6517-6526.
8. Kammler S, Leurs C, Freund M, Krummheuer J, Seidel K, Tange TO, Lund MK, Kjems J, Scheid A, Schaal H: The sequence complementarity between HIV-I 5′ splice site SD4 and UI snRNA determines the steady-state level of an unstable env pre-mRNA. Rna 2001, 7(3):421-434.
9. Staffa A, Cochrane A: Identification of positive and negative splicing regulatory elements within the terminal tat-rev exon of human immunodeficiency virus type I. Mol Cell Biol 1995, 15(8):4597-4605.
10. Zahler AM, Damgaard CK, Kjems J, Caputi M: SC3S and heterogeneous nuclear ribonucleoprotein A/B proteins bind to a juxtaposed exonic splicing enhancer/exonic splicing silencer element to regulate HIV-I tat exon 2 splicing. J Biol Chem 2004, 279(11):10077-10084.
11. Amendt BA, Hesslein D, Chang LJ, Stoltzfus CM: Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type I. Mol Cell Biol 1994, 14(6):3960-3970.
12. Bilodeau PS, Domsic JK, Mayeda A, Krainer AR, Stoltzfus CM: RNA splicing at human immunodeficiency virus type I 3′ splice site A2 is regulated by binding of hnRNP A/B proteins to an exonic splicing silencer element. J Virol 2001, 75(18):8487-8497.
13. Jacquenet S, Ropers D, Bilodeau PS, Damier L, Mougin A, Stoltzfus CM, Branlant C: Conserved stem-loop structures in the HIV-I RNA region containing the A3 3′ splice site and its cis-regulatory element: possible involvement in RNA splicing. Nucleic Acids Res 2001, 29(2):464-478.
14. Tange TO, Damgaard CK, Guth S, Valcarcel J, Kjems J: The hnRNP Al protein regulates HIV-I tat splicing via a novel intron silencer element. Embo J 2001, 20(20):5748-5758.
15. Madsen JM, Stoltzfus CM: An exonic splicing silencer downstream of the 3′ splice site A2 is required for efficient human immunodeficiency virus type I replication. J Virol 2005, 79(16):10478-10486.
16. Chang LJ, Urlacher V, Iwakuma T, Cui Y, Zucali J: Efficacy and safety analyses of a recombinant human immunodeficiency virus type I derived vector system. Gene Ther 1999, 6(5):715-728.
17. Robinson D, Elliott JF, Chang LJ: Retroviral vector with a CMVIE/HIV-TAR hybrid LTR gives high basal expression levels and is up-regulated by HIV-I Tat. Gene Ther 1995, 2(4):269-278.
18. Krummheuer J, Lenz C, Kammler S, Scheid A, Schaal H: Influence of the small leader exons 2 and 3 on human immunodeficiency virus type I gene expression. Virology 2001, 286(2):276-289.
19. Bennasser Y, Le SY, Benkirane M, Jeang KT: Evidence that HIV-I encodes an siRNA and a suppressor of RNA silencing. Immunity 2005, 22(5):607-619.
20. Roca X, Sachidanandam R, Krainer AR: Determinants of the inherent strength of human 5′ splice sites. Rna 2005, 11(5):683-698.
21. Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, Rabson A, Martin MA: Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 1986, 59(2):284-291.
22. Hughes TA, Brady HJ: Expression of axin2 is regulated by the alternative 5′-untranslated regions of its mRNA. J Biol Chem 2005, 280(9):8581-8588.
23. Willey RL, Smith DH, Lasky LA, Theodore TS, Earl PL, Moss B, Capon DJ, Martin MA: In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J Virol 1988, 62(1):139-147.
24. Kiss A, Li L, Gettemeier T, Venkatesh LK: Functional analysis of the interaction of the human immunodeficiency virus type I Rev nuclear export signal with its cofactors. Virology 2003, 314(2):591-600.
25. Marozsan AJ, Fraundorf E, Abraha A, Baird H, Moore D, Troyer R, Nankja I, Arts EJ: Relationships between infectious titer, capsid protein levels, and reverse transcriptase activities of diverse human immunodeficiency virus type I isolates. J Virol 2004, 78(20):11130-11141.
26. Bilodeau PS, Domsic JK, Stoltzfus CM: Splicing regulatory elements within tat exon 2 of human immunodeficiency virus type I (HIV-I) are characteristic of group M but not group O HIV-I strains. J Virol 1999, 73(12):9764-9772.